Analysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $8.00

Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the ten ratings firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $8.00.

Several equities research analysts have weighed in on HCAT shares. Stephens lowered their target price on shares of Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating for the company in a research note on Thursday, March 6th. KeyCorp decreased their price objective on Health Catalyst from $7.00 to $5.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Canaccord Genuity Group dropped their target price on Health Catalyst from $10.00 to $9.00 and set a "buy" rating on the stock in a research note on Thursday, May 8th. Citigroup reduced their target price on Health Catalyst from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Friday, April 25th. Finally, Stifel Nicolaus raised their price target on Health Catalyst from $5.00 to $5.50 and gave the stock a "hold" rating in a report on Thursday, May 8th.

Health Catalyst Stock Down 4.5%

Shares of NASDAQ:HCAT traded down $0.18 during trading on Friday, reaching $3.80. The stock had a trading volume of 400,659 shares, compared to its average volume of 604,867. The firm's 50-day simple moving average is $3.94 and its 200 day simple moving average is $5.27. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32. Health Catalyst has a one year low of $3.49 and a one year high of $9.24. The company has a market capitalization of $264.48 million, a P/E ratio of -2.81 and a beta of 1.53.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Quantbot Technologies LP purchased a new stake in Health Catalyst in the fourth quarter valued at approximately $29,000. Group One Trading LLC boosted its holdings in shares of Health Catalyst by 107.6% in the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company's stock valued at $31,000 after acquiring an additional 2,260 shares during the last quarter. Focus Partners Wealth acquired a new stake in shares of Health Catalyst in the first quarter worth $46,000. XTX Topco Ltd acquired a new stake in shares of Health Catalyst in the first quarter worth $54,000. Finally, Aquatic Capital Management LLC purchased a new position in shares of Health Catalyst during the fourth quarter worth $63,000. 85.00% of the stock is owned by institutional investors and hedge funds.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.